Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2013 October;148(5) > Giornale Italiano di Dermatologia e Venereologia 2013 October;148(5):493-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

REVIEWS  


Giornale Italiano di Dermatologia e Venereologia 2013 October;148(5):493-9

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

The role of sentinel lymph-node biopsy in the management of cutaneous melanoma

Crowson A. N. 1, 2, 3, 4, Haskell H. 4

1 Department of Dermatology University of Oklahoma and Regional Medical Laboratories St. John Medical Center, Tulsa, OK, USA; 2 Department of Pathology, University of Oklahoma and Regional Medical Laboratories St. John Medical Center, Tulsa, OK, USA; 3 Department of Surgery, University of Oklahoma and Regional Medical Laboratories St. John Medical Center, Tulsa, OK, USA; 4 Regional Medical Laboratories St. John Medical Center, Tulsa, OK, USA


PDF  


The use of the sentinel lymph node biopsy (SLNB) procedure has developed from an experimental technique to one that is now widely accepted for carcinoma of the breast and for cutaneous melanoma. The status of the sentinel lymph node strongly correlates with survival in patients with melanoma, and it is used in many centers to determine which patients would benefit from elective lymph node dissection and possible chemotherapy. There is emerging yet still not decisive evidence that, when combined with completion lymphadenectomy, SLNB may prolong survival in patients with metastatic disease; however, controversy continues over the lower limit of defining how large a metastatic tumor deposit must be to be meaningful. In addition, many centers are considering SLNB to help stratify risk in melanocytic lesions of uncertain malignant potential.

top of page

Publication History

Cite this article as

Corresponding author e-mail

drhaskell@sjmc.org